HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Sandler, E. D. Articles by Miller, T. R. Search for Related Content PubMed PubMed Citation Articles by Sandler, E. D. Articles by Miller, T. R.

Clinical Utility of Bone Scan Features of Pleural Effusion: Sensitivity and Specificity for Malignancy Based on Pleural Fluid Cytopathology

Department of Radiology, Nuclear Medicine Section and Pathology, University of California San Francisco, San Francisco, California

Correspondence: For correspondence contact: R.S. Hattner, MD, Nuclear Medicine Section L 340, University of California San Francisco, San Francisco, CA 94143-0252.

ABSTRACT

Asymmetric chest activity with malignant and benign pleural effusions has been described in bone scans. However, the clinical utility of this finding is not elucible from the literature. We developed specific scintigraphic criteria for malignant pleural effusion and retrospectively assessed their sensitivity and specificity in a group of patient scans. Methods: Pleural fluid was submitted for cytopathology from 850 patients over a 5-yr period. Bone scans were done within 2 mo of the thoracentesis in 74 patients. As a consensus panel, we reread the scans and reviewed the cytology. Results: The effusions were cytologically malignant in 25/74 patients (34%), indeterminate in 9/74 (12%) and benign in 40/74 (54%). Based on cytopathology, malignant pleural effusions were detected by bone scans with a sensitivity of 34%–50% and a specificity of 78%–89%; true sensitivity and specificity was somewhere in between averaging 42% (95% confidence interval 24%–60%) and 84% (95% confidence interval 73%–95%), respectively. Conclusions: The bone scan is frequently the first examination suggesting pleural metastasis, and when it is detected it should be pursued beyond pleural fluid cytology, if negative or indeterminate.

Key Words: skeletal scintigraphy • malignancy • pleural effusion

This article has been cited by other articles:

				Y. C. G. Lee and S. Wilkosz Malignant Pleural Effusions: Fixing the Leaky Faucet Am. J. Respir. Crit. Care Med., July 1, 2008; 178(1): 3 - 5. [Full Text] [PDF]

				S. Wakchoure, M. A. Merrell, W. Aldrich, T. Millender-Swain, K. W. Harris, P. Triozzi, and K. S. Selander Bisphosphonates Inhibit the Growth of Mesothelioma Cells In vitro and In vivo. Clin. Cancer Res., May 1, 2006; 12(9): 2862 - 2868. [Abstract] [Full Text] [PDF]

				K. K. Balan, S. Ramkumar, K. Faraj, and A. K. Choudhary Reduced Hemithoracic Uptake on 99mTc-MDP Bone Scintigraphy: An Underrecognized Sign of Massive Pleural Effusion--A Case Report J. Nucl. Med. Technol., March 1, 2003; 31(1): 25 - 26. [Abstract] [Full Text] [PDF]